CAH Stock Analysis: Buy, Sell, or Hold?
CAH - Cardinal Health, Inc.
$194.38
8.03 (4.31%)
▲
5d:
+4.91%
30d:
-8.24%
90d:
-9.62%
BUY
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Smart Money Distribution
CAH is up 4.9% this week, but smart money is buying puts. Top strike: $195 2026-06-18 with 2,081 OI. Put ratio: 72% View Scanner →
Strength: 4.6/10
Get Alerted When CAH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called CAH this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CAH shows positive signals but monitor for confirmation. Market pricing in 5.2% decline. Moderate conviction.
💡 BUY OPPORTUNITY: CAH shows positive signals but monitor for confirmation. Market pricing in 5.2% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$329.50
Based on 7.6% avg growth
INTRINSIC VALUE TODAY
$204.59
5.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CAH is currently trading at $194.38, which is considered slightly low relative to its 30-day fair value range of $191.03 to $213.13. From a valuation perspective, the stock is trading at a discount (Forward PE: 16.2) compared to its historical average (19.1). Remarkably, the market is currently pricing in an annual earnings decline of 5.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CAH is in a downtrend. Immediate support is located at $180.45, while resistance sits at $200.40. The stock is showing strong short-term momentum, up 4.3% recently.
Market Sentiment: CAH has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $245.27 (+26.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CAH is in a downtrend. Immediate support is located at $180.45, while resistance sits at $200.40. The stock is showing strong short-term momentum, up 4.3% recently.
Market Sentiment: CAH has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $245.27 (+26.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$191.03 -
$213.13
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.3%)
- BULLISH: Trading 26.2% below Wall St target ($245.27)
Trading Range Analysis
30-Day Trading Range
$191.03 -
$213.13
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$180.45
Resistance Level
$200.40
Current Trend
Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.23
Wall Street Target
$245.27
(+26.2%)
Revenue Growth (YoY)
11.0%
Earnings Growth (YoY)
-19.5%
Profit Margin
0.6%
Valuation Discount vs History
-5.2% cheaper
PE vs Historical
16.2 vs 19.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.2%
(market-implied from PE analysis)
1-Year Target
$184.27
(-5%)
2-Year Target
$174.69
(-10%)
3-Year Target
$165.61
(-15%)
3-Yr Target (if PE normalizes)
(PE: 16→19)
$194.91
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 11.2%)
$363.25
(+87%)
Base:
(SPY PE: 16.2, Growth: 11.2%)
$267.48
(+38%)
Bear:
(PE: 13.8, Growth: 11.2%)
$227.35
(+17%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (28x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 28.49 | Current EPS (TTM): $6.54
Bull Case
$375.41
(+93%)
Analyst growth 83.1%, PE expands to 31.3
Base Case
$341.29
(+76%)
Market implied 83.1%, PE stable at 28.5
Bear Case
$126.72
(-35%)
Severe decline -20.0%, PE contracts to 24.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.2 to 19.1
Stabilization Target:
$228.77
(+17.7%)
PE Expansion Potential:
+17.7%
Share & Embed Analysis
Last updated: May 14, 2026 7:23 PM ET
Data refreshes hourly during market hours. Next update: 8:23 PM
Data refreshes hourly during market hours. Next update: 8:23 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CAH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-02-05
Ro Khanna
SELL
2026-01-23
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$959 | 52 HOLD |
|
COR
Cencora Inc. |
BUY
17 analysts |
$365 | 57 HOLD |
|
HSIC
Henry Schein Inc |
HOLD
16 analysts |
$87 | 55 HOLD |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 53 HOLD |
|
OMI
Owens & Minor Inc |
HOLD
6 analysts |
$6 | 53 HOLD |
Advanced CAH Option Strategies
Professional options setups generated by AI based on today's CAH price and gamma walls.
